Composition for prophylaxis or treatment of IL-8 related diseases
US-12516115-B2 · Jan 6, 2026 · US
This page is not indexed by search engines while we improve data quality.
Kato Atsuhiko patents
Kato Atsuhiko is listed as an inventor on 22 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kato Atsuhiko |
| Total patents | 22 |
| First publication | Apr 23, 2015 |
| Latest publication | Jan 6, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Cancer stem cell population and method for production thereof
US-11965180-B2 · Apr 23, 2024 · US
Composition for prophylaxis or treatment of il-8 related diseases
US-2024083996-A1 · Mar 14, 2024 · US
Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies
US-2024026006-A1 · Jan 25, 2024 · US
Cancer stem cell-specific molecule
US-11858987-B2 · Jan 2, 2024 · US
Composition for prophylaxis or treatment of IL-8 related diseases
US-11780912-B2 · Oct 10, 2023 · US
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
US-11767362-B1 · Sep 26, 2023 · US
Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein
US-2023085803-A1 · Mar 23, 2023 · US
Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein
US-11536713-B2 · Dec 27, 2022 · US
Composition for prophylaxis or treatment of il-8 related diseases
US-2021301011-A1 · Sep 30, 2021 · US
Recent patents
Latest publications not already listed above.
Cancer stem cell population and method for production thereof
US-11124773-B2 · Sep 21, 2021 · US
Method for treating IL-8-related diseases
US-11053308-B2 · Jul 6, 2021 · US
Cancer stem cell-specific molecule
US-10934351-B2 · Mar 2, 2021 · US
Cancer stem cell population and method for production thereof
US-2020385686-A1 · Dec 10, 2020 · US
Cancer stem cell-specific molecule
US-2020325222-A1 · Oct 15, 2020 · US
Composition for prophylaxis or treatment of il-8 related diseases
US-2019169286-A1 · Jun 6, 2019 · US
Cancer stem cell isolation
US-10018630-B2 · Jul 10, 2018 · US
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
US-2017129950-A1 · May 11, 2017 · US
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
US-9556264-B2 · Jan 31, 2017 · US
Cancer stem cell-specific molecule
US-2016159904-A1 · Jun 9, 2016 · US
Therapeutic Agent Comprising Humanized Anti-Epiregulin Antibody as Active Ingredient for Non-Small-Cell Lung Carcinoma Excluding Adenocarcinoma
US-2016159919-A1 · Jun 9, 2016 · US
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
US-2015110793-A1 · Apr 23, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Chugai Pharmaceutical Co Ltd | 22 |
| Univ Jichi Medical | 6 |
| Nat Inst Biomedical Innovation Health & Nutrition | 6 |
| Kobayashi Shinta | 3 |
| Matsubara Koichi | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/76 | 16 |
| A61K2039/505 | 15 |
| A61P35/00 | 14 |
| C07K2317/56 | 12 |
| C07K2317/24 | 12 |